Antileukemic Activity of Sulforaphane in Primary Blasts from Patients Affected by Myelo- and Lympho-Proliferative Disorders and in Hypoxic Conditions

• Carmela Fimognari ,

  * E-mail: carmela.fimognari@unibo.it

  Affiliation Department for Life Quality Studies, Alma Mater Studiorum-University of Bologna, Rimini, Italy

  ⨯
• Eleonora Turrini,

  Affiliation Department for Life Quality Studies, Alma Mater Studiorum-University of Bologna, Rimini, Italy

  ⨯
• Piero Sestili,

  Affiliation Department of Biomolecular Sciences, University of Urbino "Carlo Bo", Urbino, Italy

  ⨯
• Cinzia Calcabrini,

  Affiliation Department of Biomolecular Sciences, University of Urbino "Carlo Bo", Urbino, Italy

  ⨯
• Giovanni Carulli,

  Affiliation Division of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

  ⨯
• Giulia Fontanelli,

  Affiliation Division of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

  ⨯
• Martina Rousseau,

  Affiliation Division of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

  ⨯
• Giorgio Cantelli-Forti,

  Affiliation Department for Life Quality Studies, Alma Mater Studiorum-University of Bologna, Rimini, Italy

  ⨯
• Patrizia Hrelia

  Affiliation Department of Pharmacy and BioTechnology, Alma Mater Studiorum-University of Bologna, Bologna, Italy

  ⨯